NYSE
Moderna Inc.
$38.37
+0.74 (1.97%)
Offline
Bull Bear Scale
MRNA
55
score
Price action
38.37
+0.74 (+1.97%)1D
Market closed · Fri, Sep 18, 9:30 AM–4:00 PM ET
Click and drag to measure a move.Use two fingers to measure a move.
Reconnecting…
No messages yet
Say hi to everyone on Bull or Bear.
Live P&L tape
Real fills on MRNA with cost-basis gains & losses
Offline
Your vote
One call per vote type per day — tap again to clear, or the other side to flip. Free accounts get 5 new calls/day across the app.
Sentiment desk
Crowd pulse, competing narratives, split news, and labeled street takes — so you can weigh bull and bear without leaving the page.
Our data
55
Crowd and tape disagree — classic two-sided tape.
Desk signals
Crowd is cautious while tape lifts — trust the lean or the print?
55% bull · 45% bear
Contest heat
Knife fight
Street mix
Street mixed
Vote fuel
Quiet room
Living narrative
Two briefs that rotate as the day’s story shifts — not a single merged take.
Bulls say
Bulls are framing this as digestion after a run, not exhaustion: as long as the shelf holds, they’re adding, not exiting.
Updates with today’s narrative
Bears say
The bear case says strength is being sold — bounce quality matters more than headlines, and follow-through has been soft.
Updates with today’s narrative
Split view
Scroll each column on its own so you can compare framing side by side.
Bull-framed
Positioning check — MRNA longs not as crowded as the timeline
The bull packet focuses on bid support and a still-open upside path if the shelf holds through the next session.
Why dip-buyers still want MRNA on weakness
The bull packet focuses on bid support and a still-open upside path if the shelf holds through the next session.
Options flow: call interest rebuilding in MRNA
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
MRNA: constructive base, bulls keep the benefit of the doubt
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Street note: upside skew still favors Moderna Inc.
Writers highlight defended levels and improving relative strength — classic “buy the dip, don’t chase the spike” tone.
Bear-framed
Supply check: who is selling MRNA into strength?
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Moderna Inc. — failed breakout risk still on the table
Put-side framing: wait for confirmation. Until then, strength is for trimming, not adding.
Macro beta could swamp the MRNA story this week
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Put buyers quietly rebuilding in MRNA
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Valuation overhang: the case against chasing Moderna Inc.
Put-side framing: wait for confirmation. Until then, strength is for trimming, not adding.
Cashtag chatter
Demo feed
Short takes labeled bull or bear. Demo stream until a live social feed is connected.
Still long $MRNA. Weak opens = inventory.
Valuation + soft follow-through. $MRNA still a fade for me.
Lower high forming in $MRNA. Patience > FOMO.
Not short yet on $MRNA — waiting for the break, not the headline.
Adding a starter in $MRNA — want follow-through, not hopium.
Lower high forming in $MRNA. Patience > FOMO.
Not short yet on $MRNA — waiting for the break, not the headline.
$MRNA needs a real flush before I get interested long.
Lower high forming in $MRNA. Patience > FOMO.
Relative strength in $MRNA vs peers is the tell.
Still long $MRNA. Weak opens = inventory.
Adding a starter in $MRNA — want follow-through, not hopium.
$MRNA bounce = exit liquidity until proven otherwise.
$MRNA bids keep showing up. Not cute — constructive.
Mock profile for MRNA used for swipe and chart demos.
Bull or Bear лише для розваг і обговорення — це не інвестиційна порада. Умови · Конфіденційність · Safety. Котирування можуть бути змодельованими або із затримкою.
